PK of Deferiprone Sustained-Release in Healthy Volunteers

Phase 1, randomised, open-label trial of deferiprone in iron overload (3 arms), sponsored by ApoPharma Inc. Primary endpoints: Area Under the Serum Concentration-Time Curve from Time Zero to Last Measurable Concentration at 24 hours, Area Under the Serum Concentration-Time Curve from Time Zero to Infinity at 24 hours and 3 more. Started May 2014; status: completed.